Prolactin Induced Protein (PIP) Antibody

Product Graph
312€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Prolactin Induced Protein (PIP) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx102474
tested applications
WB

Description

Polyclonal Antibody to Prolactin Induced Protein (PIP).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Prolactin Induced Protein (PIP)
Immunogen: PIP (Met1-Asn146)
Host
Rabbit
Reactivity
Rat
Recommended Dilution
WB: 0.01-2 µg/ml, IHC (Predicted): 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O70417
Background
Antibody anti-PIP
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Related Products

EH2124

Human PIP (Prolactin-inducible protein) ELISA Kit

Ver Producto
FNab03381

PIP antibody

GCDFP-15(gross cystic disease fluid protein 15), also known as PIP(prolactin-induced protein) is a secretory glycoprotein expressed in benign and malignant breast tumor tissues and in some normal exocrine organs such as sweat, salivary, and lacrimal glands(PMID: 12393800). GCDFP-15 expression is increased by prolactin and androgen and inhibited by estrogen(PMID: 18854942). The expression is also regulated by interleukins. GCDFP-15 is a marker of apocrine differentiation and is frequently used for assessment of metastases or regional recurrences of breast origin.

Ver Producto
P1323

Recombinant Human PIP

Ver Producto